Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients

Goldschmidt, H., Sonneveld, P., Cremer, F. W., van der Holt, B., Westveer, P., Breitkreutz, I., … Lokhorst, H. M. (2003). Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients. Annals of Hematology, 82(10), 654–659. https://doi.org/10.1007/s00277-003-0685-2